NIH Minority Health Meeting Mixes Open and Closed Sessions
Published Date: 7/15/2026
Notice
Summary
The National Institute on Minority Health and Health Disparities is holding a virtual meeting on August 31, 2026, to discuss important health topics and review grant applications. The first part of the meeting is open to the public and will be streamed online, while the last hour is closed to protect private info and trade secrets. This meeting affects researchers and communities focused on minority health and could influence future funding decisions.
Analyzed Economic Effects
4 provisions identified: 3 benefits, 0 costs, 1 mixed.
Closed Hour for Grant Application Review
From 3:00 p.m. to 4:00 p.m. on August 31, 2026, the meeting will be closed to the public to review and evaluate grant applications; the closed session is to protect confidential trade secrets, commercial property, and personal information under sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C. This meeting affects researchers and communities focused on minority health and could influence future funding decisions.
Open Session Will Be Videocast
You can watch the open part of the National Advisory Council on Minority Health and Health Disparities meeting via the NIH Videocast (http://videocast.nih.gov/) on August 31, 2026, from 10:00 a.m. to 3:00 p.m. In-person attendance is allowed but limited to space available.
Public May Submit Written Comments
Any interested person may file written comments with the committee by sending a statement (including name, address, telephone number, and when applicable business or professional affiliation) to the Contact Person listed in the notice prior to the meeting.
Reasonable Accommodations Are Available
If you plan to attend and need special assistance—such as sign language interpretation or other reasonable accommodations—you should notify the Contact Person listed in the notice in advance of the August 31, 2026 meeting.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-14133 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering new, powerful antibodies for licensing that help the immune system fight cancer better by releasing its natural brakes. This opportunity is perfect for companies ready to bring cutting-edge cancer treatments to market faster, with some international patent options available. Interested parties should act soon to explore this exciting tech and start making a difference—and money!
2026-14003 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review and decide on important research grant applications. These meetings keep sensitive info private, protecting ideas and personal details. Scientists applying for grants and the research community will feel the impact as funding decisions get made on time.
2026-14001 — National Human Genome Research Institute; Notice of Meeting
The National Human Genome Research Institute is holding a public meeting on September 28-29, 2026, to share updates and review grant applications. Scientists, researchers, and anyone interested in human genetics can join in person or online. This meeting helps decide which projects get funding, so it impacts future research and innovation in genetics.
2026-13802 — Government Owned Invention Available for License: Generating Conditional and Reverse Conditional Loss-of-Function Alleles in Mouse Casq2
The National Institutes of Health is offering special mouse strains that help study a rare heart rhythm disorder called CPVT. These mice let scientists explore how a key heart gene works and test new gene therapies. Researchers interested in this tool can access it now—no patents, just pure science ready to speed up discoveries!
2026-13612 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review and decide on important health research grant applications. These meetings keep sensitive info private to protect personal and commercial secrets. Researchers applying for grants and the public can expect no changes in funding timing or amounts, just careful, confidential reviews.
2026-13480 — Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy
The National Cancer Institute has created a special viral peptide that could help prevent and treat a serious liver cancer called HCC. This new discovery might lead to a vaccine or therapy that boosts the immune system to fight cancer better. Researchers and companies interested in developing this treatment can now license the technology, opening doors for faster progress and potential health benefits worldwide.
Previous / Next Documents
Previous: 2026-14241 — Center For Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in August 2026 to review grant applications and contract proposals related to biology, vaccine research, lung health, and diabetes. These meetings protect private info and trade secrets while deciding who gets funding. Scientists and contractors involved can expect decisions soon, but no direct money changes are announced yet.
Next: 2026-14243 — Notice of Public Meetings of the Maryland Advisory Committee to the U.S. Commission on Civil Rights
The Maryland Advisory Committee to the U.S. Commission on Civil Rights is holding free public Zoom meetings this fall to talk about how artificial intelligence affects voting. Anyone interested can join, listen, and even speak during open comment times. These meetings don’t cost money to attend, but phone users should watch for their own call charges.